Word: shuns
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Iraq the old regime wanted to avoid military retaliation or invasion, so it made sense to shun collaboration with Osama bin Laden's maximal terrorists. But since Saddam and his loyalists have lost their state, the prudence that deterred them from working with the jihadists is gone. Together or alone, the radicals must strike in Iraq, the newest "field of jihad." That phrase, redolent of Scripture, is actually a modern coinage to refer to a theater of operations for the Islamist insurgency. There are many: the U.S. and Europe have emerged as central fields of jihad, along with Egypt, Algeria...
...nuclear deterrent is the key to his survival - a belief reinforced by the fate of Saddam Hussein - and that he's rushing headlong to attain nuclear status regardless of what transpires in negotiations. After all, the nations talking to North Korea to prevent it going nuclear are unlikely to shun Pyongyang once it demonstrates nuclear capability. The examples of Israel, India and Pakistan demonstrate that nuclear capability ensures respect even from the most hostile of neighbors...
...journalists were arrested on June 4 in the country's northeast, where they were reporting on an insurgency by ethnic Hmong guerrillas. A Hmong-American interpreter was also freed, but two Laotian guides remained in prison. Brutal Youth JAPAN A 12-year-old boy admitted murdering 4-year-old Shun Tanemoto by pushing him off the roof of an eight-story parking garage, leading shocked Japanese to question their laws on juvenile crime. Because the killer is below the age of 14, he cannot be held criminally responsible. River of Death BANGLADESH The government announced two inquiries into the sinking...
...terms of close-to-market treatments, says the company's Erica Whittaker, "there's very little going on to drive sales or earnings." Turning the corner on profits is more critical than ever, because large drug companies have tired of taking big risks in biotech and tend to shun early-stage research in favor of safer investments in drugs near approval or already approved. Bristol-Myers Squibb made a disastrous $2 billion investment in 2001 in ImClone Systems, which suffered costly setbacks with its cancer drug Erbitux before a breakthrough this spring. With Big Pharma playing it safe, steady-earning...
...that regularly make money today. That number could triple by 2007, says Viren Mehta, principal at Mehta Partners, a global health-care investment group. Turning the corner on profits is more critical than ever, because large drug companies have tired of taking big risks in biotech and tend to shun early-stage research in favor of safer investments in drugs near approval or already approved. Bristol-Myers Squibb made a disastrous $2 billion investment in 2001 in ImClone Systems, which suffered costly setbacks with its cancer drug Erbitux before that drug had a breakthrough this spring. With Big Pharma playing...